MR imaging of the superior profile of the midbrain: Differential diagnosis between progressive supranuclear palsy and Parkinson disease

American Journal of Neuroradiology

Volumn 25, Issue 6, 2004, Pages 927-932

  Righini, Andrea ^a,b   Antonini, Angelo ^a   De Notaris, Roberta ^a   Bianchini, Elena ^a   Meucci, Nicoletta ^a   Sacilotto, Giorgio ^a   Canesi, Margherita ^a   De Gaspari, Danilo ^a   Triulzi, Fabio ^a   Pezzoli, Gianni ^a  

^a Istituti Clinici di Perfezionamento ^*  (Italy)

^b V BUZZI CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MESENCEPHALON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCEPHALON; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 2942633765     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620
2. Jellinger K, Riederer P, Tomonaga M. Progressive supranuclear palsy: clinico-pathological and biochemical studies. J Neural Transm 1980;16:111-128
3. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997;120:65-74
4. Polsby M, Patronas NJ, Dwyer A, et al. Progressive supranuclear palsy and magnetic resonance imaging. Neurology 1985;35:S136
5. Savoiardo M, Strada L, Girotti F, et al. MR imaging in progressive supranuclear palsy and Shy-Drager syndrome. J Comput Assist Tomogr 1989;13:55-560
6. Savoiardo M, Strada L, Girotti F, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm 1994;42:93-110
7. Aiba I, Hashizume Y, Yoshida M, et al. Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy. Study in autopsy cases. J Neurol Sci 1997;152:210-217
8. Warmuth-Metz M, Naumann M, Csoti I, et al. Measurement of the midbrain diameter on routine magnetic resonance imaging. Arch. Neurol 2001;58:1076-1079
9. Naka H, Ohshita T, Murata Y, et al. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 2002;44:204-209
10. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9
11. Daniel SE, and Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm 1993;39:165-172
12. Righini A, Antonini A, Ferrarini M, et al. Thin sections MRI study of the basal ganglia in the differential diagnosis between striatonigral Degeneration and Parkinson's disease. J Comput Assist Tomogr 2002;26:266-271
13. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697-702
14. Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986;20:744-747
15. Tohgi H, Satoshi T, Abe T, and Utsugisawa K. Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism. Eur Neurol 2001;46:1-10
16. Jellinger KA and Bancher C. Neuropatholgy. In: Litvan I, Agid Y eds. Progressive Supranuclear Palsy: Clinical and Research Approaches. Oxford: Oxford University Press, 1992;44-88
17. Stern MB, Braffman BH, Skolnick BE, et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989;39:1524-1526
18. Kraft E, Schwarz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2 weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56:225-228
19. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;suppl:78-89
20. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98